Saturday, 7 April 2012

Food And Drug Administration-Bristol-Myers Squibb-Complete Response-Clinical Studies

Our readers tested the most popular strategies so you won't have to. Try the one...

Our readers tested the most popular strategies so you won't have to. Try the ones that fit your life and get ready to watch the pounds drop off. http://on.self.com/wpw020Diet advice that workswww.self.comSELF Magazine: fashion, beauty, health, sex advice, news read more..

source:self.com

Beauty products can go bad, too! Here are a few things to look for when deciding...

Beauty products can go bad, too! Here are a few things to look for when deciding whether to keep or toss your beauty products: http://on.self.com/wYKKAkHow To Tell If Your Beauty Products Have Gone Bad www.self.comSELF Magazine: fashion, beauty, health, sex advice, news read more..

source:self.com

U.S. rebuffs AstraZeneca, Bristol on diabetes drug

LONDON (Reuters) - U.S. drug regulators need further clinical data, possibly including new clinical studies, before approving a new diabetes drug from AstraZeneca and Bristol-Myers Squibb. The two companies said on Thursday they had received a so-called "complete response letter" from the Food And Drug Administration (FDA) for dapagliflozin as a treatment for type 2 diabetes in adults. The news is a setback for both drugmakers, compounding other recent pipeline disappointments in cancer for Bristol, and both cancer and depression for AstraZeneca. ... read more..

No comments:

Post a Comment